Search This Blog

Friday, November 15, 2019

FDA OKs Cooper contact lens that slows progression of nearsightedness in kids

The FDA approves Cooper Companies (NYSE:COO) unit CooperVision’s MiSight contact lens, the first in the U.S. indicated to slow the progression of myopia (nearsightedness) in children between the ages of 8 and 12 at the start of treatment.
The disposable lens is designed for single use, to be discarded at the end of each day.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.